Ke Gong, Junming Tang, Viktoria Stanislavovna Berestovskaya, Teppo Heimo, Hao Wang, Hui Huang et al. Residual cardiovascular risk beyond LDL-C in ASCVD: Biological drivers, biomarkers, and therapeutic strategies. // Acta Pharmaceutica Sinica B. – 2026. – DOI: 10.1016/j.apsb.2026.11.011. – URL: https://doi.org/10.1016/j.apsb.2026.11.011
Ke Gong, Junming Tang, Viktoria Stanislavovna Berestovskaya, Teppo Heimo, Hao Wang, Hui Huang, & Yajun Duan (2026). Residual cardiovascular risk beyond LDL-C in ASCVD: Biological drivers, biomarkers, and therapeutic strategies. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2026.11.011
Ke Gong, et al. “Residual cardiovascular risk beyond LDL-C in ASCVD: Biological drivers, biomarkers, and therapeutic strategies.” Acta Pharmaceutica Sinica B, 2026. doi:10.1016/j.apsb.2026.11.011.
@article{Gong2026,
title = {Residual cardiovascular risk beyond LDL-C in ASCVD: Biological drivers, biomarkers, and therapeutic strategies},
author = {Gong, Ke and Tang, Junming and Berestovskaya, Viktoria Stanislavovna and Heimo, Teppo and Wang, Hao and Huang, Hui and Duan, Yajun},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
doi = {10.1016/j.apsb.2026.11.011},
url = {https://doi.org/10.1016/j.apsb.2026.11.011}
}